Literature DB >> 20653060

Association of glypican-3 expression with growth signaling molecules in hepatocellular carcinoma.

Noriyuki Akutsu1, Hiroyuki Yamamoto, Shigeru Sasaki, Hiroaki Taniguchi, Yoshiaki Arimura, Kohzoh Imai, Yasuhisa Shinomura.   

Abstract

AIM: To clarify the association of glypican-3 (GPC3) expression with Wnt and other growth signaling molecules in hepatocellular carcinoma (HCC).
METHODS: Expression of GPC3, Wnt, matrix metalloproteinases (MMPs), sulfatase (SULF)1, SULF2, and other growth signaling molecules was analyzed in HCC cell lines and tissue samples by real-time reverse transcription-polymerase chain reaction, immunoblotting, and/or immunostaining. Expression of various genes in GPC3 siRNA-transfected HCC cells was analyzed.
RESULTS: GPC3 was overexpressed in most HCCs at mRNA and protein levels and its serum levels were significantly higher in patients with HCC than in non-HCC subjects (P < 0.05). Altered expressions of various MMPs and growth signaling molecules, some of which were correlated with GPC3 expression, were observed in HCCs. Down-regulation of GPC3 expression by siRNA in GPC3-overexpressing HCC cell lines resulted in a significant decrease in expressions of MMP2, MMP14, fibroblast growth factor receptor 1, insulin-like growth factor 1 receptor. GPC3 expression was significantly correlated with nuclear/cytoplasmic localization of beta-catenin.
CONCLUSION: These results suggest that GPC3, in conjunction with MMPs and growth signaling molecules, might play an important role in the progression of HCC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20653060      PMCID: PMC2909551          DOI: 10.3748/wjg.v16.i28.3521

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  33 in total

1.  Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver.

Authors:  X R Xu; J Huang; Z G Xu; B Z Qian; Z D Zhu; Q Yan; T Cai; X Zhang; H S Xiao; J Qu; F Liu; Q H Huang; Z H Cheng; N G Li; J J Du; W Hu; K T Shen; G Lu; G Fu; M Zhong; S H Xu; W Y Gu; W Huang; X T Zhao; G X Hu; J R Gu; Z Chen; Z G Han
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

2.  Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders.

Authors:  Z W Zhu; H Friess; L Wang; M Abou-Shady; A Zimmermann; A D Lander; M Korc; J Kleeff; M W Büchler
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

3.  Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling.

Authors:  Yutaka Midorikawa; Shumpei Ishikawa; Hiroko Iwanari; Takeshi Imamura; Hirohiko Sakamoto; Kohei Miyazono; Tatsuhiko Kodama; Masatoshi Makuuchi; Hiroyuki Aburatani
Journal:  Int J Cancer       Date:  2003-02-10       Impact factor: 7.396

4.  Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis.

Authors:  H C Hsu; Y M Jeng; T L Mao; J S Chu; P L Lai; S Y Peng
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

5.  Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma.

Authors:  Mariana Capurro; Ian R Wanless; Morris Sherman; Gerrit Deboer; Wen Shi; Eiji Miyoshi; Jorge Filmus
Journal:  Gastroenterology       Date:  2003-07       Impact factor: 22.682

6.  Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker.

Authors:  Tetsuya Nakatsura; Yoshihiro Yoshitake; Satoru Senju; Mikio Monji; Hiroyuki Komori; Yutaka Motomura; Seiji Hosaka; Toru Beppu; Takatoshi Ishiko; Hidenobu Kamohara; Hiroshi Ashihara; Toyomasa Katagiri; Yoichi Furukawa; Shigetoshi Fujiyama; Michio Ogawa; Yusuke Nakamura; Yasuharu Nishimura
Journal:  Biochem Biophys Res Commun       Date:  2003-06-20       Impact factor: 3.575

Review 7.  Caught up in a Wnt storm: Wnt signaling in cancer.

Authors:  Rachel H Giles; Johan H van Es; Hans Clevers
Journal:  Biochim Biophys Acta       Date:  2003-06-05

8.  Glypican-3 regulates migration, adhesion and actin cytoskeleton organization in mammary tumor cells through Wnt signaling modulation.

Authors:  Ivan Stigliano; Lydia Puricelli; Jorge Filmus; Mari Cleide Sogayar; Elisa Bal de Kier Joffé; María Giselle Peters
Journal:  Breast Cancer Res Treat       Date:  2008-04-11       Impact factor: 4.872

9.  Glypican-3 is overexpressed in human hepatocellular carcinoma.

Authors:  Young Kwan Sung; Sun Young Hwang; Mi Kyung Park; Mohammad Farooq; In Sook Han; Han Ik Bae; Jung-Chul Kim; Moonkyu Kim
Journal:  Cancer Sci       Date:  2003-03       Impact factor: 6.716

10.  Inhibition of invasion and metastasis by glypican-3 in a syngeneic breast cancer model.

Authors:  M G Peters; E Farías; L Colombo; J Filmus; L Puricelli; E Bal de Kier Joffé
Journal:  Breast Cancer Res Treat       Date:  2003-07       Impact factor: 4.872

View more
  9 in total

1.  Diagnostic accuracy of serum squamous cell carcinoma antigen and squamous cell carcinoma antigen-immunoglobulin M for hepatocellular carcinoma: A meta-analysis.

Authors:  Jian Zhang; Chuxiao Shao; Qingyun Zhou; Yimin Zhu; Jinde Zhu; Chaoyong Tu
Journal:  Mol Clin Oncol       Date:  2015-07-08

2.  Sulfatase-1 knockdown promotes in vitro and in vivo aggressive behavior of murine hepatocarcinoma Hca-P cells through up-regulation of mesothelin.

Authors:  Salma Abdi Mahmoud; Mohammed Mohammed Ibrahim; Ahmed Hago Musa; Yuhong Huang; Jun Zhang; Jingwen Wang; Yuanyi Wei; Li Wang; Shunting Zhou; Boyi Xin; Wei Xuan; Jianwu Tang
Journal:  J Cell Commun Signal       Date:  2017-12-23       Impact factor: 5.782

3.  Expression of GPC3 protein and its significance in lung squamous cell carcinoma.

Authors:  Qiang Lin; Li-Wen Xiong; Xu-Feng Pan; Jun-Feng Gen; Guo-Liang Bao; Hui-Fang Sha; Jiu-Xian Feng; Chun-Yu Ji; Ming Chen
Journal:  Med Oncol       Date:  2011-05-10       Impact factor: 3.064

4.  Suppression of glypican 3 inhibits growth of hepatocellular carcinoma cells through up-regulation of TGF-β2.

Authors:  Chris K Sun; Mei-Sze Chua; Jing He; Samuel K So
Journal:  Neoplasia       Date:  2011-08       Impact factor: 5.715

5.  A wrinkle in time: circadian biology in pulmonary vascular health and disease.

Authors:  Andrew J Bryant; Elnaz Ebrahimi; Amy Nguyen; Christopher A Wolff; Michelle L Gumz; Andrew C Liu; Karyn A Esser
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-12-01       Impact factor: 5.464

6.  Glypican-3 Expression in Patients with Oral Squamous Cell Carcinoma.

Authors:  Azadeh Andisheh-Tadbir; Amir Saeed Goharian; Mohammad Ali Ranjbar
Journal:  J Dent (Shiraz)       Date:  2020-06

7.  Transcriptome profiles associated with selenium-deficiency-dependent oxidative stress identify potential diagnostic and therapeutic targets in liver cancer cells.

Authors:  Damla Gözen; Deniz Cansen Kahraman; Kübra Narci; Huma Shehwana; Özlen Konu; Rengül Çetin-Atalay
Journal:  Turk J Biol       Date:  2021-04-20

8.  Human Monoclonal Antibody Targeting the Heparan Sulfate Chains of Glypican-3 Inhibits HGF-Mediated Migration and Motility of Hepatocellular Carcinoma Cells.

Authors:  Wei Gao; Heungnam Kim; Mitchell Ho
Journal:  PLoS One       Date:  2015-09-02       Impact factor: 3.240

9.  Autophagy suppresses proliferation of HepG2 cells via inhibiting glypican-3/wnt/β-catenin signaling.

Authors:  Pei Hu; Bin Cheng; Yulin He; Zhiqiang Wei; Dongfang Wu; Zhongji Meng
Journal:  Onco Targets Ther       Date:  2018-01-04       Impact factor: 4.147

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.